4//SEC Filing
Anderson Robert A. 4
Accession 0001493152-22-034379
CIK 0001712762other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 9:31 PM ET
Size
21.4 KB
Accession
0001493152-22-034379
Insider Transaction Report
Form 4
Anderson Robert A.
Director
Transactions
- Purchase
Common Stock, par value $0.007
2022-08-31+4,081→ 4,081 total - Purchase
Warrants (right to buy)
2022-08-31+4,081→ 4,081 totalExercise: $7.35From: 2022-08-31Exp: 2027-08-31→ Common Stock (4,081 underlying) - Purchase
Non-tradeable Warrants (right to buy)
2022-08-31+4,081→ 4,081 totalExercise: $7.66From: 2022-08-31Exp: 2027-08-31→ Common Stock (4,081 underlying)
Footnotes (2)
- [F1]The number of securities and exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the "Common Stock"), of bioAffinity Technologies, Inc. (the "Issuer"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the "IPO").
- [F2]The reported securities are included within 4,081 Units purchased by Mr. Anderson for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share.
Documents
Issuer
bioAffinity Technologies, Inc.
CIK 0001712762
Entity typeother
Related Parties
1- filerCIK 0001730173
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 9:31 PM ET
- Size
- 21.4 KB